Thursday, 28 October 2021 18:34

: Merck’s COVID-19 pill could bring in up to $7 billion in sales next year

Written by MarketWatch
Rate this item
(0 votes)
Merck & Co. Inc. predicts it will make between $5 billion and $7 billion in sales of its experimental and potentially game-changing new oral COVID-19 drug by the end of 2022 if it's authorized this year.

Read more from our friends at MarketWatch

Read 433 times